Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(66.7%)

N/A

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 4(4)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02702778Phase 2Terminated

Delayed Release Prednisone in PMR

Role: collaborator

NCT02842554Phase 4Completed

Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies

Role: lead

NCT01562353Unknown

Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction

Role: lead

NCT01770964Phase 4Unknown

Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy

Role: lead

NCT01557816Not ApplicableUnknown

Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee

Role: lead

NCT01329406Phase 4Unknown

Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis

Role: lead

NCT01264237Phase 4Unknown

Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain

Role: lead

NCT01166295Unknown

Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia

Role: lead

NCT00794651Unknown

Osteoarthritis Bedside Testing Kit

Role: lead

All 9 trials loaded